APRE
Aprea Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.76
+1.32%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.08
- Revenue estimate
- $307.5K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.07
- EPS estimate
- -$0.18
- Revenue actual
- —
- Revenue estimate
- $253.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -61.1%
- Revenue beats (12Q)
- 2
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.18 | -$0.07 | Beat 60.56% | — |
| May 13, 2026 | -$0.23 | -$0.22 | Beat 4.35% | $281.0K |
| Mar 16, 2026 | -$0.39 | -$0.32 | Beat 17.95% | $3.3K |
| Nov 12, 2025 | -$0.11 | -$0.47 | Miss -327.27% | $1.8K |
| Aug 12, 2025 | -$0.77 | -$0.53 | Beat 31.17% | $118.1K |
| May 14, 2025 | -$0.65 | -$0.66 | Miss -0.87% | $162.5K |
| Mar 25, 2025 | -$0.69 | -$0.49 | Beat 28.99% | $205.8K |
| Nov 7, 2024 | -$0.75 | -$0.64 | Beat 14.67% | $354.6K |
| May 14, 2024 | -$0.78 | -$0.67 | Beat 14.10% | $380.6K |
| Nov 9, 2023 | -$1.08 | -$0.86 | Beat 20.37% | $319.5K |
| Aug 10, 2023 | -$1.43 | -$0.87 | Beat 39.16% | $249.7K |
| May 15, 2023 | -$1.51 | -$1.34 | Beat 11.26% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026